Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 13 Oct 2020 for AKCEA THERAPEUTICS, INC., €3.7M. Read the official filing
Filing timeline
BuySaleDamien McDevitt
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Damien McDevitt: trading record in brief
Filings by Damien McDevitt span 2 companies, the busiest being Akcea Therapeutics, Inc. and Ionis Pharmaceuticals Inc. Between 1 July 2019 and 12 October 2020, the trades on record add up to 10 filings.
No open-market purchase appears, only 2 sales worth €238k. Other entries cover 5 share grants and 1 option exercise. In 2020 alone, the filings show no purchases and 2 sales.
Most recently, on 13 October 2020, the filings show a transaction worth €3.7M in Akcea Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Damien McDevitt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
242,978 shares@ US$18.1593.7% of flowCommon StockSEC:0001209191-20-054613:0
8,709 shares@ US$18.123.4% of flowCommon StockSEC:0001209191-20-051888:0
1,104 shares@ US$14.400.3% of flowCommon StockSEC:0001209191-20-049120:0
60,000 shares0Common StockSEC:0001209191-20-021951:0
9,417 shares@ US$11.752.6% of flowCommon StockSEC:0001209191-20-021118:0
55,200 shares0Common StockSEC:0001209191-20-020632:0
200,000 shares0Common StockSEC:0001209191-19-050481:0
3,542 shares0Common StockSEC:0000874015-19-000114:0
1,225 shares@ US$67.8687.7% of flowCommon StockSEC:0000874015-19-000114:1
256 shares@ US$45.7012.3% of flowCommon StockSEC:0000874015-19-000081:0
10 of 10 declarations
